HU
Hospital Universitario Infanta Leonor at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
Hospital Universitario Infanta Leonor brings 2 presentations to IDWeek 2026 in Washington. Its program centres on real-world use of long-acting cabotegravir plus rilpivirine for HIV. One study follows immune changes after patients switch to the regimen, and another looks at older people with HIV and multiple chronic conditions in the RELATIVITY cohort.
| Organization | IDWeek 2026 Attendance |
|---|---|
HU Hospital Universitario Infanta Leonor Madrid, Spain | |
Poster Fri Oct 23 12:15pm–1:30pm Beyond Viral Suppression: Immunologic Evolution After Switching to Long-Acting Cabotegravir Plus Rilpivirine in Real-World Practice Poster Fri Oct 23 12:15pm–1:30pm Long-Acting Cabotegravir plus Rilpivirine in People With HIV Aged ≥60 Years: Real-World Evidence From the RELATIVITY Cohort in the Context of Multimorbidity |
Instantly find 20 buyers from Hospital Universitario Infanta Leonor
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction